Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
D000912:Antibodies, Neoplasm / Q000032:analysis*; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001500:BCG Vaccine / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D002462:Cell Membrane / Q000276:immunology; D002675:Child, Preschool; D003168:Complement Fixation Tests; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D004166:Diphtheria Antitoxin / Q000627:therapeutic use; D005153:Facial Neoplasms / Q000188:drug therapy; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D010567:Pertussis Vaccine / Q000627:therapeutic use; D013743:Tetanus Antitoxin / Q000627:therapeutic use
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001500:BCG Vaccine; D004166:Diphtheria Antitoxin; D010567:Pertussis Vaccine; D013743:Tetanus Antitoxin; D003561:Cytarabine; D008727:Methotrexate